X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DR. REDDYS LAB - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DR. REDDYS LAB J.B.CHEMICALS/
DR. REDDYS LAB
 
P/E (TTM) x 17.6 19.8 88.9% View Chart
P/BV x 2.2 3.0 75.0% View Chart
Dividend Yield % 0.5 0.8 66.4%  

Financials

 J.B.CHEMICALS   DR. REDDYS LAB
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
DR. REDDYS LAB
Mar-19
J.B.CHEMICALS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3632,875 12.6%   
Low Rs2551,888 13.5%   
Sales per share (Unadj.) Rs169.1930.2 18.2%  
Earnings per share (Unadj.) Rs16.6117.4 14.1%  
Cash flow per share (Unadj.) Rs23.4185.8 12.6%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.60.8 77.1%  
Book value per share (Unadj.) Rs172.5844.4 20.4%  
Shares outstanding (eoy) m83.57166.07 50.3%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.6 71.4%   
Avg P/E ratio x18.620.3 91.8%  
P/CF ratio (eoy) x13.212.8 102.9%  
Price / Book Value ratio x1.82.8 63.5%  
Dividend payout %12.017.0 70.7%   
Avg Mkt Cap Rs m25,827395,496 6.5%   
No. of employees `0003.822.0 17.2%   
Total wages/salary Rs m2,51133,562 7.5%   
Avg. sales/employee Rs Th3,747.47,032.8 53.3%   
Avg. wages/employee Rs Th665.71,527.9 43.6%   
Avg. net profit/employee Rs Th367.8887.7 41.4%   
INCOME DATA
Net Sales Rs m14,135154,482 9.1%  
Other income Rs m3663,375 10.8%   
Total revenues Rs m14,501157,857 9.2%   
Gross profit Rs m2,17831,782 6.9%  
Depreciation Rs m57011,348 5.0%   
Interest Rs m35889 3.9%   
Profit before tax Rs m1,94022,920 8.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5523,858 14.3%   
Profit after tax Rs m1,38719,500 7.1%  
Gross profit margin %15.420.6 74.9%  
Effective tax rate %28.516.8 169.2%   
Net profit margin %9.812.6 77.7%  
BALANCE SHEET DATA
Current assets Rs m10,470111,101 9.4%   
Current liabilities Rs m2,74958,973 4.7%   
Net working cap to sales %54.633.7 161.9%  
Current ratio x3.81.9 202.2%  
Inventory Days Days5579 69.6%  
Debtors Days Days7894 82.4%  
Net fixed assets Rs m5,811101,245 5.7%   
Share capital Rs m167830 20.1%   
"Free" reserves Rs m14,248139,406 10.2%   
Net worth Rs m14,416140,236 10.3%   
Long term debt Rs m022,000 0.0%   
Total assets Rs m17,649224,656 7.9%  
Interest coverage x56.626.8 211.2%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.7 116.5%   
Return on assets %8.19.1 88.8%  
Return on equity %9.613.9 69.2%  
Return on capital %13.714.9 91.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16488,673 7.0%   
Fx outflow Rs m1,33419,104 7.0%   
Net fx Rs m4,82969,569 6.9%   
CASH FLOW
From Operations Rs m1,23128,704 4.3%  
From Investments Rs m-208-7,727 2.7%  
From Financial Activity Rs m-595-21,326 2.8%  
Net Cashflow Rs m427-314 -136.0%  

Share Holding

Indian Promoters % 55.4 25.5 217.3%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.4 62.8%  
FIIs % 3.9 35.3 11.0%  
ADR/GDR % 0.0 18.5 -  
Free float % 37.0 15.3 241.8%  
Shareholders   30,437 75,885 40.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Erase Gains; Sensex Ends 52 Points Higher(Closing)

After opening the day higher, Indian share markets witnessed negative trading activity during closing hours and ended their trading session marginally higher.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

My Top 3 Dividend Millionaire Stocks(Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 19, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS